Skip to main content
Livermore
Livermore
ZHEN

Boston Partners

SEC CIK
0001386060
Latest filing
Aug 4, 2026

NVS holding history

Novartis AG in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
53,689
Value
$8.39M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVS by Boston Partners, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202653,689$8.39M<0.1%−1,484−2.7%ReducedHolders
Q1 202655,173$8.43M<0.1%+7,869+16.6%AddedHolders
Q4 202547,304$6.53M<0.1%−7,239−13.3%ReducedHolders
Q3 202554,543$7.01M<0.1%+1,813+3.4%AddedHolders
Q2 202552,730$6.37M<0.1%+11,247+27.1%AddedHolders
Q1 202541,483$4.62M<0.1%−11,876−22.3%ReducedHolders
Q4 202453,359$5.19M<0.1%+16,320+44.1%AddedHolders
Q3 202437,039$4.26M<0.1%+1,572+4.4%AddedHolders
Q2 202435,467$3.78M<0.1%+17,450+96.9%AddedHolders
Q1 202418,017$1.74M<0.1%−13,759−43.3%ReducedHolders
Q4 202331,776$3.21M<0.1%+1,836+6.1%AddedHolders
Q3 202329,940$3.05M<0.1%+2,250+8.1%AddedHolders
Q2 202327,690$2.79M<0.1%00.0%UnchangedHolders
Q1 202327,690$2.55M<0.1%−2,410−8.0%ReducedHolders
Q4 202230,100$2.73M<0.1%−1,742,349−98.3%ReducedHolders
Q3 20221,772,449$135.1M0.2%−2,811,869−61.3%ReducedHolders
Q2 20224,584,318$387.7M0.5%−25,857−0.6%ReducedHolders
Q1 20224,610,175$405.0M0.5%−67,228−1.4%ReducedHolders
Q4 20214,677,403$409.2M0.5%+292,854+6.7%AddedHolders
Q3 20214,384,549$358.6M0.5%−1,915,211−30.4%ReducedHolders
Q2 20216,299,760$574.8M0.7%+439,189+7.5%AddedHolders
Q1 20215,860,571$501.2M0.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.